Dr. Gruia has served as a member of our board of directors since May 2021. Dr. Gruia founded Gabriela Gruia Consulting, LLC in January 2021. Prior to that, Dr. Gruia served as the Chief Development Officer at Ichnos Sciences Inc. from February 2020 to January 2021. Prior to her time at Ichnos Sciences Inc., Dr. Gruia served as Senior Vice President and Head of Drug Regulatory Affairs for Novartis Oncology from 2008 through 2020. Dr. Gruia currently serves on the boards of directors for Tessa Therapeutics, Inc. and Molecular Templates, Inc.
Dr. Gruia received her doctorate in medicine from Bucharest Medical School in Romania and a Masters in Breast Pathology and Mammography from Rene Huguenin/Curie Institute Cancer Center in Paris, France. She received her training in oncology and hematology from Rene Descartes University in Paris, France.